InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Kidron Nadav, Chairman & CEO. Insider active across 3 companies, notably Oramed Pharmaceuticals INC.. In total, 25 filings have been recorded. Breakdown: 2 buys · 2 sells. Total volume traded: €7.8m. History available since 9 August 2021. The latest transaction was filed on 21 August 2026 (X). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Kidron Nadav
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
10,000 shares@ US$1.50Ordinary SharesSEC:0001104659-26-100937:0
44,818 shares@ US$3.311.6% of flowCommon StockSEC:0001213900-26-037447:0
7,657 shares0Ordinary Shares, no par value per shareSEC:0001178913-26-001814:0
167,005 shares0Common StockSEC:0001213900-26-031013:0
100,000 shares0Common StockSEC:0001213900-26-028291:0
109,000 shares0Common StockSEC:0001213900-26-009479:0
232,640 shares0Common StockSEC:0001213900-26-001280:0
141,000 shares0Common StockSEC:0001213900-25-012239:0
433,500 sharesCommon StockSEC:0001213900-25-001168:0
45,000 sharesCommon StockSEC:0001213900-24-095931:0
329,000 sharesCommon StockSEC:0001209191-24-001151:0
120,000 sharesCommon StockSEC:0001209191-23-033145:0
279,000 sharesCommon StockSEC:0001209191-23-024939:0
26,000 shares@ US$2.0390.3% of flowCommon StockSEC:0001209191-23-019367:0
Canonical exit: 14 Jun 2023 (T+90)
100,000 shares@ US$2.011.2% of flowCommon StockSEC:0001209191-23-018956:0
Canonical exit: 12 Jun 2023 (T+90)
25,000 shares0Common StockSEC:0001209191-22-054879:0
34,000 sharesCommon StockSEC:0001209191-22-043768:0
150,000 sharesCommon StockSEC:0001213900-22-001613:0
150,000 sharesCommon StockSEC:0001213900-22-000818:0
31,728 shares@ US$12.988.1% of flowCommon StockSEC:0001213900-21-068231:0
220,000 shares@ US$20.10522.21% mcap23.8% of flowCommon StockSEC:0001213900-21-063945:0
100,000 sharesCommon StockSEC:0001213900-21-063944:0
20,000 sharesCommon StockSEC:0001213900-21-063983:0
100,000 sharesCommon StockSEC:0001213900-21-046407:0
220,000 shares@ US$20.105283.8% of flowCommon StockSEC:0001213900-21-041711:0
25 of 25 declarations
About Kidron Nadav
KIDRON NADAV is Président-Directeur Général. He has 24 filings in total, and in the recent sampled filings covered here the activity runs from 2021-08-11 to 2026-03-31, with EUR 237504 of buys and EUR 7536153 of sells; the modal transaction nature is Attribution. He is also linked to Oramed Pharmaceuticals INC. as President and CEO and to Lifeward Ltd. as Director.
